Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AVARA Rx vs PreventiveMD

AVARA Rx
Graded #266

Lower grade

vs+13.299999999999997
PreventiveMD
Graded #54

Higher grade

The verdict

PreventiveMD takes it — 76.1/100 to 62.8/100.

PreventiveMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. PreventiveMD is a physician-guided telehealth platform for GLP-1 weight loss and peptide therapy, offering compounded semaglutide from $83/mo all-in and compounded tirzepatide from $97/mo all-in, plus brand…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePreventiveMD +41
43
84
Dose & formulationPreventiveMD +5
77
82
Clinical oversightPreventiveMD +6
76
82
Labs & monitoringPreventiveMD +1
52
53
FulfillmentPreventiveMD +6
77
83
Contract termsEven
55
55
AVARA Rx · left barPreventiveMD · right bar

The numbers

MetricAVARA RxPreventiveMD
WeighScore62.8/10076.1/100
GradeCC
Scorecard rank#266#54
Semaglutide$229/mo (starting dose, compounded)$83/mo (starting dose, compounded)
Tirzepatide$279/mo (starting dose, compounded)$97/mo (starting dose, compounded)
CoverageAll 50 states36 states
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
AVARA Rx

Graded #266 · C

Strengths

  • Names its pharmacy partner (DiRx Health, Ft Lauderdale FL) — buyers can independently verify its licensure
  • Names its clinical network (Beluga Health) — you can research the platform handling your prescriptions
  • All 50 states explicitly listed on the FAQ — uncommon vs peers that just say 'nationwide'
  • Patient-friendly refunds — full refund if a provider disqualifies you, partial if a weaker dose is prescribed
  • LegitScript verification badge displayed; pharmacy claims NABP-accredited facilities

Where it loses points

  • Operating legal entity not disclosed — only a Sheridan, WY registered-agent-style address surfaced
  • Dose pricing not itemized — only 'starting at $229' semaglutide and 'starting at $279' tirzepatide
  • LegitScript certification number not shown — badge only, so no direct lookup
  • No named medical director (Beluga Health is the network, not a named MD)
  • Lab work requirements not specified, and consultation fee not broken out from medication cost
PreventiveMD

Graded #54 · C

Strengths

  • Compounded semaglutide from $83/mo and tirzepatide from $97/mo, billed as one all-in monthly price
  • Brand Wegovy, Zepbound, and Foundayo (oral GLP-1) available on the same platform
  • US-licensed provider reviews requests within 24 hours — no video visit required
  • You aren't charged until a provider approves; checkout places an authorization hold only
  • LegitScript-certified; works exclusively with state-licensed US 503A compounding pharmacies

Where it loses points

  • Individual compounding pharmacy partners are not publicly named
  • Not available in 14 states + DC, including New York, New Jersey, Virginia, and Wisconsin
  • Brand Wegovy, Zepbound, and Foundayo require a $49/mo membership fee on top of medication cost
  • 'As low as' pricing — actual monthly cost can be higher depending on your plan
  • Orders become non-refundable once provider review or pharmacy fulfillment begins

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard